Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Current Assets (2021 - 2025)

Coeptis Therapeutics Holdings has reported Current Assets over the past 5 years, most recently at $7.4 million for Q4 2025.

  • Quarterly results put Current Assets at $7.4 million for Q4 2025, up 599.15% from a year ago — trailing twelve months through Dec 2025 was $7.4 million (up 599.15% YoY), and the annual figure for FY2025 was $7.4 million, up 599.15%.
  • Current Assets for Q4 2025 was $7.4 million at Coeptis Therapeutics Holdings, up from $6.0 million in the prior quarter.
  • Over the last five years, Current Assets for COEPW hit a ceiling of $7.4 million in Q4 2025 and a floor of $30967.0 in Q3 2022.
  • Median Current Assets over the past 5 years was $1.7 million (2023), compared with a mean of $2.3 million.
  • Biggest five-year swings in Current Assets: plummeted 94.87% in 2022 and later soared 5132.91% in 2023.
  • Coeptis Therapeutics Holdings' Current Assets stood at $2.2 million in 2021, then skyrocketed by 80.85% to $3.9 million in 2022, then plummeted by 55.61% to $1.7 million in 2023, then plummeted by 39.92% to $1.1 million in 2024, then soared by 599.15% to $7.4 million in 2025.
  • The last three reported values for Current Assets were $7.4 million (Q4 2025), $6.0 million (Q3 2025), and $3.7 million (Q2 2025) per Business Quant data.